Implication of human herpesviruses in oncogenesis through immune evasion and supression

被引:48
作者
Alibek, Kenneth [1 ,2 ]
Baiken, Yeldar [1 ]
Kakpenova, Ainur [1 ]
Mussabekova, Assel [1 ]
Zhussupbekova, Samal [1 ]
Akan, Madina [1 ]
Sultankulov, Bolat [1 ]
机构
[1] Nazarbayev Univ, Astana 010000, Kazakhstan
[2] Natl Med Holding, Astana 010000, Kazakhstan
关键词
Herpesviruses; Cancer; Immune system; Antigen presentation; Natural killer cells; Cytokine; EPSTEIN-BARR-VIRUS; HERPES-SIMPLEX-VIRUS; VARICELLA-ZOSTER-VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS; CD4(+) T-CELLS; HUMAN CYTOMEGALOVIRUS; CYTOKINE SYNTHESIS; GASTRIC-CARCINOMA; INFECTIOUS AGENTS; PERIPHERAL-BLOOD;
D O I
10.1186/1750-9378-9-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
All human herpesviruses (HHVs) have been implicated in immune system evasion and suppression. Moreover, two HHV family members, i.e. EBV and KSHV, are recognised as oncogenic viruses. Our literature review summarises additional examples of possible oncogenic mechanisms that have been attributed to other HHVs. In general, HHVs affect almost every cancer-implicated branch of the immune system, namely tumour-promoting inflammation, immune evasion, and immunosuppression. Some HHVs accomplish these effects by inhibiting apoptotic pathways and by promoting proliferation. Mechanisms related to immunosupression and low grade chronic inflammation could eventually result in the initiation and progression of cancer. In this article we open a discussion on the members of Herpesviridae, their immune evasion and suppression mechanisms, and their possible role in cancer development. We conclude that discerning the mechanisms of interplay between HHV, immune system, and cancer is essential for the development of novel preventative and therapeutic approaches for cancer treatment and prophylaxis.
引用
收藏
页数:8
相关论文
共 79 条
[1]   Role of infectious agents in the carcinogenesis of brain and head and neck cancers [J].
Alibek, Kenneth ;
Kakpenova, Ainur ;
Baiken, Yeldar .
INFECTIOUS AGENTS AND CANCER, 2013, 8
[2]   Chromosomally-integrated human herpesvirus 6 in familial glioma etiology [J].
Amirian, E. Susan ;
Scheurer, Michael E. .
MEDICAL HYPOTHESES, 2012, 79 (02) :193-196
[3]   Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus [J].
Areste, Cristina ;
Blackbourn, David J. .
TRENDS IN MICROBIOLOGY, 2009, 17 (03) :119-129
[4]   Aging, immunity, and the varicella-zoster virus [J].
Arvin, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (22) :2266-2267
[5]   Memory cytotoxic T cell responses to viral tegument and regulatory proteins encoded by open reading frames 4, 10, 29, and 62 of varicella-zoster virus [J].
Arvin, AM ;
Sharp, M ;
Moir, M ;
Kinchington, PR ;
Sadeghi-Zadeh, M ;
Ruyechan, WT ;
Hay, J .
VIRAL IMMUNOLOGY, 2002, 15 (03) :507-516
[6]   Modulatory effects of human herpes virus-7 on cytokine synthesis and cell proliferation in human peripheral blood mononuclear cell cultures [J].
Atedzoé, BN ;
Menezes, J ;
D'Addario, M ;
Xu, JW ;
Ongradi, J ;
Ahmad, A .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (05) :822-828
[7]  
BALFOUR HH, 1988, AM J MED, V85, P68
[8]   Herpes simplex inhibits the capacity of lymphoblastoid B cell lines to stimulate CD4+ T cells [J].
Barcy, S ;
Corey, L .
JOURNAL OF IMMUNOLOGY, 2001, 166 (10) :6242-6249
[9]   Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis [J].
Cai, Qiliang ;
Verma, Suhbash C. ;
Lu, Jie ;
Robertson, Erle S. .
ADVANCES IN VIRUS RESEARCH, VOL 78, 2010, 78 :87-142
[10]   EBV-associated lymphoproliferative disorders: Classification and treatment [J].
Carbone, Antonino ;
Gloghini, Annunziata ;
Dotti, Giampietro .
ONCOLOGIST, 2008, 13 (05) :577-585